AIDX 20/20 Biolabs, Inc.
Company Analysis
Latest News
🔴 20/20 Biolabs is trading 5.1% down today amid softening small-cap risk appetite
20/20 Biolabs is trading 5.1% down at $0.50 in after-hours trading, primarily driven by a broader softening in small-cap risk appetite. • The move extends a...
🔴 20/20 Biolabs is trading 5% down today tracking weak small-cap risk tone
20/20 Biolabs is trading at $0.49 (-5.02%) as the stock tracks a broader weak small-cap risk tone with no clear company-specific catalyst in available...
🔴 20/20 Biolabs is trading 5.1% down today in a technical pullback following a sentiment-driven rebound
20/20 Biolabs is trading 5.1% down at $0.52 as the stock undergoes a technical pullback following a short-term, sentiment-driven rebound on July 15, 2026. •...
🔴 20/20 Biolabs is trading 5.2% down today after yesterday’s short-term rebound
20/20 Biolabs is trading 5.2% down at $0.52 in pre-market sessions following a short-term rebound in the previous session. • The move follows a prior...
🟢 20/20 Biolabs is trading 6% up today as it extends a short-term rebound on no clear news catalyst
20/20 Biolabs is trading approximately 6% higher at $0.59 in pre-market as it extends a short-term rebound from recent weakness. • The move appears to be...
🟢 20/20 Biolabs is trading 9.1% up today as it extends a rebound on no clear news catalyst
20/20 Biolabs is trading at $0.60 (up 9.1%) in pre-market action, extending a modest rebound from recent weakness despite a lack of fundamental news. • The...
🟢 20/20 Biolabs is trading 6.2% up today, rebounding from recent weakness on no clear news catalyst
20/20 Biolabs is trading at $0.58 (6.2% up) in after-hours trading, rebounding modestly from recent weakness despite a lack of fresh news. • No...
🔴 20/20 Biolabs is trading 5.8% down today amid broader biotech sector weakness
20/20 Biolabs is trading at $0.56 (-5.76%) as it extends a pullback from its recent AI-driven rebound, largely tracking a downturn in the broader industry. •...
🔴 20/20 Biolabs is trading 5.7% down today as it gives back gains from its recent AI-driven rebound
20/20 Biolabs is trading 5.7% down at $0.55 today, retracing a portion of its recent gains following industry recognition for its clinical AI tools. • The...
🟢 20/20 Biolabs is trading 6.4% up today as AMIA recognition of its clinical AI tools sustains momentum
20/20 Biolabs is trading at $0.61 (6.4% up) as the company continues to see positive momentum following industry recognition of its artificial intelligence...
🟢 AIDX Rises 3.39% in Pre-Market Following AMIA Recognition for Clinical AI Advancement
• AIDX is trading at $0.61 (+3.39%) in pre-market trading today, rebounding from a prior weak session. • The upward movement follows news on July 7, 2026, that...
🔴 AIDX is trading 5.4% down today amid thin liquidity and micro-cap volatility
AIDX is trading 5.4% down at $0.59 today, driven by thin liquidity and a broader risk-off market tone. • The move comes despite a lack of new company-specific...
🔴 AIDX is trading 5.9% down today amid thin liquidity and risk-off sentiment
AIDX is trading at $0.59, down 5.9%, following a modest multi-day rebound observed in late June and early July. • There are currently no fresh...
🟢 AIDX is trading 5.9% up today after its acquisition-heavy growth plan webinar
AIDX is trading 5.9% up now at $0.65 as investors react to its July 1 investor webinar outlining an aggressive buy‑and‑build acquisition strategy and scaling...
20/20 Biolabs Pitches a Buy-and-Build Future, but Can a $6 Million Company Really Pull Off an Acquisition Spree?
Shares of 20/20 Biolabs (AIDX) slid 9.6% to $0.55 on July 2 as investors digested the company's inaugural investor webinar, held July 1, which laid out an...
🔴 AIDX is trading 9.6% down today as investors digest new strategy and M&A plans
AIDX is trading at $0.55 (9.6% down) as investors react to the company's recently unveiled strategic roadmap and M&A objectives. • The price movement follows...
AIDX Outlines M&A Strategy and Path to Medicare Reimbursement for OneTest
In a new investor presentation, 20/20 Biolabs (AIDX) detailed its corporate strategy, which includes a new "bolt-on" acquisition plan and its pathway to...
🟢 AIDX makes sharp 15.3% jump
AIDX is trading at $0.63, up 15.3% versus the comparison close of $0.55 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 AIDX Rises 5.2% on Technical Bounce, Amidst Investor Webinar
AIDX is trading 5.2% up at $0.58 in a technical bounce following yesterday's sharp 7.9% decline. The company is hosting a monthly investor webinar today, which...
🔴 AIDX makes sharp 10.7% drop
AIDX is trading at $0.53, down 10.7% versus the comparison close of $0.60 during regular trading. This is a price-movement alert; no separate company-specific...